CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
118 hedge funds and large institutions have $213M invested in Cymabay Therapeutics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 25 reducing their positions, and 17 closing their positions.
Holders
118
Holders Change
+5
Holders Change %
+4.42%
% of All Funds
1.87%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
22
Increased
38
Reduced
25
Closed
17
Calls
$805K
Puts
$456K
Net Calls
+$349K
Net Calls Change
+$956K
Top Buyers
1 |
CC
1
Commodore Capital
New York
|
$17.8M |
2 |
2
Millennium Management
New York
|
$7.38M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$3.01M |
4 |
4
Renaissance Technologies
New York
|
$1.43M |
5 |
HS
5
HighVista Strategies
Boston,
Massachusetts
|
$645K |